RIVAROXABAN(Xarelto®)
Clinical Indication
Prevention of VTE in adults undergoing hip or knee replacement
Date of classification
November 2017
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.